Stratification of Biologic Therapies for RA by Pathobiology (STRAP): A randomised, open-labelled biopsy-driven stratification trial in DMARD inadequate responder patients randomised to Etanercept, Tocilizumab or Rituximab.

Trial Profile

Stratification of Biologic Therapies for RA by Pathobiology (STRAP): A randomised, open-labelled biopsy-driven stratification trial in DMARD inadequate responder patients randomised to Etanercept, Tocilizumab or Rituximab.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Rituximab (Primary) ; Etanercept; Tocilizumab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms STRAP
  • Most Recent Events

    • 31 Oct 2015 Accrual to date is 1% according to United Kingdom Clinical Research Network record.
    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top